Form 4 for URGN UroGen Pharma Ltd.
Accepted 2023-09-05 00:00:00 ET · period of report 2023-08-31 · accession 0001437749-23-025204 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-05 | 2023-08-31 | URGN | Smith Jason Drew | GC | S - Sale+OE | $18.01 | -3,800 | 18.4K | -17% | -$68.4K |
| D | 2023-09-05 | 2023-08-31 | URGN | Smith Jason Drew | GC | M - OptEx | — | +8,334 | 22.2K | +60% | — |
| D | 2023-09-05 | 2023-08-31 | URGN | Smith Jason Drew | GC | M - OptEx | $0.00 | -8,334 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-08-31 | S | D | 3,800 | $18.01 | 18,407 | D | — | — | (F2) Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. |
| 2 | Common | Ordinary Shares | 2023-08-31 | M | A | 8,334 | — | 22,207 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. |
| 3 | Derivative | Restricted Stock Units | 2023-08-31 | M | D | 8,334 | $0.00 | 0 | D | — · — to — | 8,334 Ordinary Shares | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. (F3) The reporting person was granted RSUs on August 31, 2020 representing 25,000 ordinary shares. The RSUs vested in three equal installments on November 30, 2021, August 31, 2022 and August 31, 2023. |